GlassScriptPhysician profile
Roshni Rao
NPI 1639136963
$1,096.96
in general payments reported to CMS, 2019-2025
14 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.65 · 2021: $13.66 · 2022: $265 · 2023: $160 · 2024: $210 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Entertainment: $47.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.59 |
| Entertainment | $47.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $246.90 | 2022-2025 | Savi Scout |
| Impedimed, INC. | $210.70 | 2025 | |
| Tactile Systems Technology INC | $133.39 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | |
| Smith+Nephew, INC. | $82.13 | 2022 | |
| Kub Technologies INC. | $47.43 | 2023 | Mozart |
| Dilon Technologies, INC. | $43.66 | 2023 | Hemoblast Bellows |
| Regeneron Healthcare Solutions, INC. | $43.65 | 2019 | |
| Axogen | $36.47 | 2022 | |
| Puma Biotechnology, INC. | $29.84 | 2025 | |
| Tempus Ai, INC | $28.61 | 2024 | Xt Cdx |
| Genentech USA, INC. | $26.46 | 2023 | Phesgo |
| Bard Peripheral Vascular, INC. | $23.24 | 2023 | |
| Novartis Pharmaceuticals Corporation | $19.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roshni Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.